Literature DB >> 23121460

Boric acid irrigation as an adjunct to mechanical periodontal therapy in patients with chronic periodontitis: a randomized clinical trial.

Mehmet Sağlam1, Uğur Arslan, Şerife Buket Bozkurt, Sema S Hakki.   

Abstract

BACKGROUND: The purpose of this single-masked, randomized, controlled clinical trial was to evaluate the effects of boric acid irrigation as an adjunct to scaling and root planing (SRP) on clinical and microbiologic parameters and compare this method with chlorhexidine irrigation and SRP alone in patients with chronic periodontitis (CP).
METHODS: Forty-five systemically healthy patients with CP are included in this study. They were divided into three groups: 1) SRP + saline irrigation (C); 2) SRP + chlorhexidine irrigation (CHX); and 3) SRP + boric acid irrigation (B). To determine an ideal concentration of boric acid, a preclinical analysis was conducted. At baseline, 1 month, and 3 months after treatment, clinical measurements, including plaque index (PI), gingival index (GI), probing depth (PD), clinical attachment level (CAL), and bleeding on probing (BOP), were performed, and subgingival plaque samples were taken. Quantitative analysis of Porphyromonas gingivalis (Pg), Tannerella forsythia (Tf), and Treponema denticola (Td) was performed using real-time polymerase chain reaction (PCR) procedures.
RESULTS: The concentration of boric acid is 0.75% in this study. All clinical parameters showed statistically significant reduction at all time points compared to baseline in all groups (P <0.001). Whole-mouth PD and CAL reduction was similar in all groups at all time points after treatment (P >0.05). The PD and CAL reductions for moderately deep pockets (PD ≥5 and <7) were greater in the B group compared to other groups between baseline and 1 month (P <0.05). For deep pockets (PD ≥7), reductions were similar in the B and CHX groups (P >0.05). BOP (percentage) was significantly lower in the B group compared with the CHX and C groups in the first month after treatment (P <0.001). GI and PI scores were significantly lower in the B and CHX groups compared with the C group at all time points after treatment (P <0.05). The amounts of Pg, Tf, and Td were significantly reduced in all treatment groups after 1 month (P <0.05). No statistically significant differences were detected among the groups for microbiologic parameters at any time points after treatment (P >0.05).
CONCLUSIONS: The results of this study suggest that boric acid could be an alternative to chlorhexidine, and it might be more favorable because boric acid was superior in whole-mouth BOP as well as PD and CAL reduction for moderate pockets in early time periods.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23121460     DOI: 10.1902/jop.2012.120467

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  10 in total

1.  pH influences the biocompatibility of methylene blue solutions.

Authors:  David Jonathan Rodrigues Gusman; Luciano Tavares Angelo Cintra; Vivian Cristina Noronha Novaes; Henrique Rinaldi Matheus; Nathália Januario de Araujo; Juliano Milanezi de Almeida
Journal:  Clin Oral Investig       Date:  2017-05-23       Impact factor: 3.573

2.  Management of Chronic Periodontitis Using Subgingival Irrigation of Ozonized Water: A Clinical and Microbiological Study.

Authors:  Annie V Issac; Jayan Jacob Mathew; Majo Ambooken; Arun Jose Kachappilly; Ajithkumar Pk; Thomas Johny; Linith Vk; Anju Samuel
Journal:  J Clin Diagn Res       Date:  2015-08-01

Review 3.  Preprocedural mouth rinses for preventing transmission of infectious diseases through aerosols in dental healthcare providers.

Authors:  Sumanth Kumbargere Nagraj; Prashanti Eachempati; Martha Paisi; Mona Nasser; Gowri Sivaramakrishnan; Tony Francis; Jos H Verbeek
Journal:  Cochrane Database Syst Rev       Date:  2022-08-22

4.  Boric acid inhibits alveolar bone loss in rat experimental periodontitis through diminished bone resorption and enhanced osteoblast formation.

Authors:  Nazmus Shalehin; Akihiro Hosoya; Hiroaki Takebe; Md Riasat Hasan; Kazuharu Irie
Journal:  J Dent Sci       Date:  2020-01-21       Impact factor: 2.080

Review 5.  Professionally Delivered Local Antimicrobials in the Treatment of Patients with Periodontitis-A Narrative Review.

Authors:  Amar Sholapurkar; Dileep Sharma; Beverley Glass; Catherine Miller; Alan Nimmo; Ernest Jennings
Journal:  Dent J (Basel)       Date:  2020-12-22

6.  Efficacy of Preprocedural Boric Acid Mouthrinse in Reducing Viable Bacteria in Dental Aerosols Produced during Ultrasonic Scaling.

Authors:  Swet Nisha; Avinash Bettahalli Shivamallu; Sheela Kumar Gujjari; Pratibha Shashikumar; Nada Musharraf Ali; Madhuri Kulkarni
Journal:  Contemp Clin Dent       Date:  2021-09-21

7.  Metal ions from S-PRG filler have the potential to prevent periodontal disease.

Authors:  Yoko Iwamatsu-Kobayashi; Syouta Abe; Yoshiyasu Fujieda; Ai Orimoto; Masafumi Kanehira; Keisuke Handa; Venkata Suresh Venkataiah; Wei Zou; Masaki Ishikawa; Masahiro Saito
Journal:  Clin Exp Dent Res       Date:  2017-08-10

8.  Antiseptics as adjuncts to scaling and root planing in the treatment of periodontitis: a systematic literature review.

Authors:  Egle Ramanauskaite; Vita Machiulskiene
Journal:  BMC Oral Health       Date:  2020-05-18       Impact factor: 2.757

9.  Comparative Evaluation of Boric Acid Gel versus Chlorhexidine Gel in the Treatment of Chronic Periodontitis: Randomized, Placebo-Controlled Clinical Study.

Authors:  Alefiya Mamajiwala; Kunal Sunder Sethi; Swapna A Mahale; Chetan Purushottam Raut; Prerna A Karde; Aishwarya M Kale
Journal:  Contemp Clin Dent       Date:  2019 Jul-Sep

10.  Clinical and Microbiological Effects of Weekly Supragingival Irrigation with Aerosolized 0.5% Hydrogen Peroxide and Formation of Cavitation Bubbles in Gingival Tissues after This Irrigation: A Six-Month Randomized Clinical Trial.

Authors:  Gediminas Žekonis; Renata Šadzevičienė; Ingrida Balnytė; Viktorija Noreikienė; Gaida Marija Šidlauskaitė; Eglė Šadzevičiūtė; Jonas Žekonis
Journal:  Oxid Med Cell Longev       Date:  2020-07-31       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.